CD8A and neoplasm: Ultimately, in PDX tumor models, Nb-TriTE treatment outperforms Nb-BiTE treatment with increased antitumor efficacy and more CD3+CD8+ T cell infiltration in the tumor and spleen, and immune checkpoint blockade not only leads to reversal of T cell inhibition but also affects the other immune cells, such as dendritic cells (DC).